SCHEMBL20148988

SCHEMBL20148988

COC(=O)CCC(=O)OCCOC(=O)CCl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.56
ADRA2A P08913 1/20 0.45
ADRA1A P35348 1/20 0.45
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
BLM P54132 1/20 0.43
LMNA P02545 3/20 0.42
CA12 O43570 3/20 0.42
CA14 Q9ULX7 3/20 0.42
DGKA P23743 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.37
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25492396 0.89 TSHR (0.72) TSHRADRA2AADRA1AKMT2AMAPT
SCHEMBL12377230 0.82 TSHR (0.62) TSHRADRA2AADRA1AKMT2AMAPT
SCHEMBL1036146 0.81 TSHR (0.39) TSHRADRA2AADRA1AMAPTBLM
SCHEMBL8476442 0.79 TSHR (0.65) TSHRADRA2AADRA1AKMT2AMAPT
SCHEMBL5325979 0.79
SCHEMBL813658 0.79 TSHR (0.75) TSHRADRA2AADRA1AKMT2AMAPT
SCHEMBL775807 0.77 TSHR (0.62) TSHRADRA2AADRA1AKMT2AMAPT
SCHEMBL12846426 0.77 TSHR (0.62) TSHRADRA2AADRA1AKMT2AMAPT
Ethylene SCHEMBL3383723 0.76 DGKA (0.36) TSHRADRA2AADRA1AMAPTBLM
SCHEMBL7622921 0.76 TSHR (0.59) TSHRADRA2AADRA1AKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10905711-B2 Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal VIFOR (INTERNATIONAL) LTD. (CH) 2021-02-02 US disclosed
US-20180133244-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY REMOVING POTASSIUM ION FROM THE GASTROINTESTINAL TRACT OF A MAMMAL VIFOR (INTERNATIONAL) LTD. (CH) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10905711-B2 Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal KCNN3, KCNH3, KCNH2 TSHR 2033/4885ADRA2A 904/4885ADRA1A 781/4885
US-20180133244-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY REMOVING POTASSIUM ION FROM THE GASTROINTESTINAL TRACT OF A MAMMAL KCNN3, KCNH3, KCNH2 TSHR 2033/4885ADRA2A 904/4885ADRA1A 781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.